# FDA recall D-0354-2023

> **Sciegen Pharmaceuticals Inc** · Class III · drug recall initiated 2023-02-17.

## Product

Gabapentin Tablets, USP 600 mg, 500 tablets per bottle, RX Only, Manufactured by ScieGen Pharmaceuticals Inc., Hauppauge, NY 11788, NDC: 50228-177-05.

## Reason for recall

Presence of Foreign Tablets/Capsules: Pharmacist reported presence of some Gabapentin tablets 800 mg comingled in Gabapentin 600 mg 500 count bottles.

## Distribution

Nationwide in the USA and Puerto Rico

## Key facts

- **Recall number:** D-0354-2023
- **Recalling firm:** Sciegen Pharmaceuticals Inc
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2023-02-17
- **Report date:** 2023-03-08
- **Termination date:** 2024-06-17

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Hauppauge, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0354-2023

## Citation

> AI Analytics. FDA recall D-0354-2023. Retrieved 2026-07-06 from https://api.ai-analytics.org/recall/D-0354-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*